BRCA1 and breast cancer: Considering the different forms of breast cancer presentation, patients in the familial group showed higher levels of resolvin D1 vs. controls (p = 0.01), and a similar behavior was observed vs. the mutated BRCA1/2 group (p = 0.056); this trend was present also for resolvin D1 when comparing the sporadic group vs. controls (p = 0.055) (Figure 2).